- Filed
- Mar 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 30.49M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 30.46M sh |
| Capex | FY 2025 · Dec 31, 2025 | $289K |
| Capex | FY 2025 · Dec 31, 2024 | $1.3M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$39.92M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$30.96M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $125.55M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $172.68M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $140.35M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $182.27M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $218.85M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $7.93M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $15.11M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $9.73M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $16.83M |
| Current Assets | FY 2025 · Dec 31, 2025 | $126.95M |
| Current Assets | FY 2025 · Dec 31, 2024 | $174.57M |
| Total Assets | FY 2025 · Dec 31, 2025 | $150.08M |
| Total Assets | FY 2025 · Dec 31, 2024 | $199.09M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$1.49 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$1.26 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$1.49 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$1.26 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $8.3M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $4.71M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $47.39M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $37.76M |
| Net Income | FY 2025 · Dec 31, 2025 | −$45.54M |
| Net Income | FY 2025 · Dec 31, 2024 | −$38.53M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$55.69M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$42.47M |